Jiafeng Liang

Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.

Cyclofenil blocks the secretion of IL-1β by inhibiting assembly of the NLRP3 inflammasome independent of estrogen receptor.

Journal: Molecular biology reports
Published: May 18, 2026

Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer.

Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer.

Journal: Discover oncology
Published: December 15, 2025

Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma.

Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma.

Journal: Journal of thoracic disease
Published: August 14, 2025

Hyperthermia correlates with low incidence of radiation pneumonitis after thoracic radiotherapy: a retrospective study.

Hyperthermia correlates with low incidence of radiation pneumonitis after thoracic radiotherapy: a retrospective study.

Journal: BMC cancer
Published: May 31, 2025

Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase Ⅱ study.

Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase Ⅱ study.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 12, 2025

Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study.

Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study.

Journal: Discover oncology
Published: November 22, 2024

Role of TLR7 expression in cancer: impact on immune activation and prognostic evaluation.

Role of TLR7 expression in cancer: impact on immune activation and prognostic evaluation.

Journal: Journal of translational medicine
Published: July 07, 2024

Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation.

Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation.

Journal: Discover oncology
Published: June 18, 2024

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity.

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity.

Journal: Discover oncology
Published: March 22, 2024

CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway.

CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 14, 2023

The second-generation tyrosine kinase inhibitor afatinib inhibits IL-1β secretion via blocking assembly of NLRP3 inflammasome independent of epidermal growth factor receptor signaling in macrophage.

The second-generation tyrosine kinase inhibitor afatinib inhibits IL-1β secretion via blocking assembly of NLRP3 inflammasome independent of epidermal growth factor receptor signaling in macrophage.

Journal: Molecular immunology
Published: May 27, 2022

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study.

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study.

Journal: BMC cancer
Published: January 20, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026